Sarepta Therapeutics (SRPT) PT Lowered to $35 at Oppenheimer
Tweet
Share
E-mailGet Alerts SRPT Hot Sheet
Price: $20.11 -2.71%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Join SI Premium – FREE
Oppenheimer analyst Andreas Argyrides lowered the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $35.00 (from $37.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Securitize Corp (SECZ) PT Raised to $12 at StoneX on 'Innovation Exemption'
- Dowa Holdings Co Ltd (5714:JP) PT Raised to JPY9,800 at Nomura/Instinet
- Bank of Hangzhou Co Ltd (600926:CH) PT Raised to RMB17.30 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
